1. Home
  2. TYGO vs XOMA Comparison

TYGO vs XOMA Comparison

Compare TYGO & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tigo Energy Inc.

TYGO

Tigo Energy Inc.

HOLD

Current Price

$3.43

Market Cap

281.4M

Sector

Technology

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$26.38

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYGO
XOMA
Founded
2007
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.4M
308.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYGO
XOMA
Price
$3.43
$26.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$60.60
AVG Volume (30 Days)
418.0K
118.2K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,014,000.00
N/A
Revenue This Year
$27.36
$76.93
Revenue Next Year
$25.52
$29.28
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$18.40
52 Week High
$4.50
$39.92

Technical Indicators

Market Signals
Indicator
TYGO
XOMA
Relative Strength Index (RSI) 48.51 50.33
Support Level $3.19 $23.92
Resistance Level $4.41 $27.61
Average True Range (ATR) 0.39 1.47
MACD -0.06 0.12
Stochastic Oscillator 21.87 47.54

Price Performance

Historical Comparison
TYGO
XOMA

About TYGO Tigo Energy Inc.

Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: